Pharmacosmos Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMACOSMOS, and when can generic versions of PHARMACOSMOS drugs launch?
PHARMACOSMOS has two approved drugs.
There are seventeen US patents protecting PHARMACOSMOS drugs.
There are one hundred and seventy-three patent family members on PHARMACOSMOS drugs in thirty countries and one supplementary protection certificate in one country.
Summary for Pharmacosmos
| International Patents: | 173 |
| US Patents: | 17 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| PTAB Cases with Pharmacosmos as petitioner: | See PTAB cases with Pharmacosmos as petitioner |
Drugs and US Patents for Pharmacosmos
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacosmos | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | 10,414,831 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Pharmacosmos | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 8,598,186 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Pharmacosmos | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 9,957,276 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Pharmacosmos | COSELA | trilaciclib dihydrochloride | POWDER;INTRAVENOUS | 214200-001 | Feb 12, 2021 | RX | Yes | Yes | 10,966,984 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Pharmacosmos Drugs
Supplementary Protection Certificates for Pharmacosmos Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2411053 | C02411053/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
